Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigger Point Injection Added to Caudal Epidural Steroid for Low Back and Hip Pain
NCT05792111Phase 4Unknown
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in myofascial pain syndrome (MPS), low back pain (LBP), Hip pain, sponsored by Bolu Abant Izzet Baysal University. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
myofascial pain syndrome (MPS)low back pain (LBP)Hip pain
Beyond the preview
Go deeper on NCT05792111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792111.